BELIXOS

LIVE

Serial Number

79070762

Owner

Biofrontera Pharma GmbH

Attorney

Jennifer Fraser

Filing Date

May 27, 2009

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

BELIXOS Trademark

Serial Number: 79070762 • Registration: 3771836

BELIXOS is a trademark filed by Biofrontera Pharma GmbH on May 27, 2009. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Biofrontera Pharma GmbH (8 trademarks)

Hemmelrather Weg 201
Leverkusen 51377 , DE

Entity Type: 99

Legal Representation

Attorney of Record

Jennifer Fraser

2,431 trademarks filed View all →

Trademark Details

Filing Date

May 27, 2009

Registration Date

April 6, 2010

Published for Opposition

January 19, 2010

Cancellation Date

February 26, 2021

Goods & Services

Pharmaceutical preparations for the treatment and prevention of dermatological diseases and skin disorders; medicines for human purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; medicines for veterinary purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for medical purposes, namely, pharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for veterinary purposes, namely, medicines for the treatment of dermatological diseases and skin disorders; topical ointment and gels for the medical and therapeutic treatment of dermatological diseases and skin disorders; [ * all aforementioned goods not for the treatment of cancer and leukemia and the treatment of adverse effects of the treatment of cancer and leukemia, in particular not for pharmaceutical preparations on the basis of mistletoe for the treatment of pre-cancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plamacytoma, for the stimulation of the bone marrow function and nutritional or dietary supplements * ] * all aforementioned goods not for the treatment of cancer and leukemia and the treatment of side-effects occurring during the treatment of cancer and leukemia, particularly pharmaceutical preparations on the basis of mistletoes for the treatment of precancerous lesions, solid tumors, malignant hemoblastoses, leukemias, lymphogranulomatosis, lymphomas, plasmacytoms, for stimulating the bone marrow functions and as nutritional supplements *

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB

Jan 15, 2022 INNT

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Dec 19, 2021 INTS

INVALIDATION PROCESSED

Dec 18, 2021 INPC

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

Oct 26, 2021 INTR

CANCELLED SECTION 71

Feb 26, 2021 C71T

INTERNATIONAL REGISTRATION RENEWED

Jun 13, 2019 RNWL

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

Apr 6, 2019 REM4

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 12, 2017 TCCA

PARTIAL INVALIDATION PROCESSED BY THE IB

May 12, 2017 INNP

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Sep 8, 2016 INPS

INVALIDATION PROCESSED

Sep 8, 2016 INPC

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

Sep 8, 2016 INPR

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

Jan 8, 2016 NA71

REGISTERED-SEC.71 ACCEPTED

Jan 8, 2016 71AG

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jan 8, 2016 APRE

TEAS SECTION 71 RECEIVED

Nov 28, 2015 ES71

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Aug 28, 2015 TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Aug 27, 2015 TCCA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

Jul 15, 2015 INNA

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

Mar 24, 2015 INPR

CORRECTION UNDER SECTION 7 - PROCESSED

Jul 24, 2014 COC.

ASSIGNED TO PARALEGAL

Jul 24, 2014 PLGL

LIMITATION FROM THE IB EXAMINED AND ENTERED

Jul 23, 2014 LIME

LIMITATION OF GOODS RECEIVED FROM IB

Jul 4, 2014 LIMG

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

Apr 30, 2014 INNA

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

Jun 4, 2013 INPR

FINAL DECISION TRANSACTION PROCESSED BY IB

Feb 7, 2013 FINO

CORRECTION UNDER SECTION 7 - PROCESSED

Oct 4, 2012 COC.

ASSIGNED TO PARALEGAL

Oct 4, 2012 PLGL

LIMITATION FROM THE IB EXAMINED AND ENTERED

Oct 4, 2012 LIME

LIMITATION OF GOODS RECEIVED FROM IB

Sep 28, 2012 LIMG

FINAL DISPOSITION NOTICE SENT TO IB

Jul 28, 2010 FICS

FINAL DISPOSITION PROCESSED

Jul 28, 2010 FIMP

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

Jul 28, 2010 LIMN

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jul 7, 2010 FICR

REGISTERED-PRINCIPAL REGISTER

Apr 6, 2010 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 19, 2010 NPUB

PUBLISHED FOR OPPOSITION

Jan 19, 2010 PUBO

LAW OFFICE PUBLICATION REVIEW COMPLETED

Dec 14, 2009 PREV

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 11, 2009 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 11, 2009 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 11, 2009 CRFA

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Dec 11, 2009 CHAN

ASSIGNED TO LIE

Dec 11, 2009 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 24, 2009 TROA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Nov 24, 2009 TCCA

LIMITATION OF GOODS RECEIVED FROM IB

Nov 6, 2009 LIMG

REFUSAL PROCESSED BY IB

Sep 29, 2009 RFNT

CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED

Sep 23, 2009 CORR

CORRECTION TRANSACTION RECEIVED FROM IB

Sep 18, 2009 CRCV

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Sep 4, 2009 RFCS

REFUSAL PROCESSED BY MPU

Sep 4, 2009 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Sep 4, 2009 RFCR

NON-FINAL ACTION WRITTEN

Sep 3, 2009 CNRT

ASSIGNED TO EXAMINER

Aug 27, 2009 DOCK

APPLICATION FILING RECEIPT MAILED

Aug 11, 2009 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 7, 2009 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Aug 6, 2009 REPR

Related Trademarks

More from this Owner

RHODOLED XL

NATURAL HERITAGE WITH HERBAL BIOCOLLOIDS

More in Same Class

TEST & GO TECHNOLOGY